[HTML][HTML] Islet cells in human type 1 diabetes: from recent advances to novel therapies–a symposium-based roadmap for future research

J Cantley, DL Eizirik, E Latres… - Journal of …, 2023 - joe.bioscientifica.com
There is a growing understanding that the early phases of type 1 diabetes (T1D) are
characterised by a deleterious dialogue between the pancreatic beta cells and the immune …

Liraglutide protects β-cells in novel human islet spheroid models of type 1 diabetes

B Yesildag, J Mir-Coll, A Neelakandhan, CB Gibson… - Clinical …, 2022 - Elsevier
To enable accurate, high-throughput and longer-term studies of the immunopathogenesis of
type 1 diabetes (T1D), we established three in-vitro islet-immune injury models by culturing …

Cohort profile: the 'Biomarkers of heterogeneity in type 1 diabetes' study—a national prospective cohort study of clinical and metabolic phenotyping of individuals with …

HJ Aanstoot, RDM Varkevisser, D Mul, P Dekker… - BMJ open, 2024 - bmjopen.bmj.com
Purpose The 'Biomarkers of heterogeneity in type 1 diabetes' study cohort was set up to
identify genetic, physiological and psychosocial factors explaining the observed …

[HTML][HTML] Cohort profile: Cohort profile: the 'Biomarkers of heterogeneity in type 1 diabetes' study—a national prospective cohort study of clinical and metabolic …

HJ Aanstoot, RDM Varkevisser, D Mul, P Dekker… - BMJ Open, 2024 - ncbi.nlm.nih.gov
Purpose The 'Biomarkers of heterogeneity in type 1 diabetes' study cohort was set up to
identify genetic, physiological and psychosocial factors explaining the observed …

Vitamin D and type 1 diabetes

PJ Martens, C Gysemans, C Mathieu - Feldman and Pike's Vitamin D, 2024 - Elsevier
This chapter provides an overview on the association between vitamin D and type 1
diabetes. Despite a clear genetic predisposition, the exact trigger of type 1 diabetes remains …

[HTML][HTML] 100 YEARS OF INSULIN: 100 years of insulin: progress, current perspectives and future challenges

J Cantley, D Eizirik - Journal of Endocrinology, 2022 - joe.bioscientifica.com
100 YEARS OF INSULIN: 100 years of insulin: progress, current perspectives and future
challenges in: Journal of Endocrinology Volume 252 Issue 3 (2022) Jump to Content Journal of …

[HTML][HTML] Механізм дії та особливості застосування холекальциферолу в дітей та підлітків на етапах розвитку цукрового діабету 1-го типу

VV Popova, NV Het, YI Labanets… - Ендокринологія …, 2023 - endokrynologia.com.ua
Анотація У статті узагальнено та проаналізовано матеріал, присвячений
проспективним довгостроковим клініко-імунологічним дослідженням. Створено Реєстр …

[PDF][PDF] Physiological and Immunological Variables in Patients with Type 2 Diabetes

WM Mutar, QA Ahmed, KK Abdullah - researchgate.net
Diabetes mellitus is a chronic disease caused by various factors Genetic, viral,
environmental, or functional, and it is not a single disease, but several diseases that affect …

Okoljski dejavniki razvoja sladkorne bolezni tipa 1

K Valentinčič - 2021 - repozitorij.uni-lj.si
ŠD Du1 DK UDK 606: 616.379-008.64: 577.27 (043.2) KG avtoimunost, črevesna
mikrobiota, epigenetika, imunski sistem, prehrana, preventiva, probiotiki, prebiotiki …